Graymark Capital is an industry-leading commercial real estate firm, headquartered in San Francisco, California.
We invest in institutional quality Life Science, office, R & D and industrial properties in the Western U.S. that appeal to today's modern tenants.
Since 2012, Graymark Capital has purchased 34 Life Science, office, R&D and industrial properties comprising over
4.1 million square feet and over $1.7 billion of value.
Presenting “Gray Matter”, the Life Science initiative of Graymark Capital, Inc.
